Business Wire26d
World’s First Drug Candidate developed by Organoid and AI Doses First Patient in Phase 1 Study for first Diffusive Gastric Cancer Targeted Therapy
This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to ...
The Scientist11mon
Selecting Cytokines for Organoid Cultures
Scientists optimize organoid culture growth and consistency with validated growth factor panels. Researchers can optimize organoid culture growth and consistency with panels of growth factors that are ...